Publications (97) FRANCISCO MANUEL GONZALEZ SAIZ publications

filter_list

2025

  1. Factors related to painful somatic symptoms in patients with depression: The role of gender and anhedonia

    Psychiatry Research Communications, Vol. 5, Núm. 1

2024

  1. Assessing predictors of adequate individual buprenorphine maintenance dosage for the treatment of opioid use disorder: Listening to the patient

    International Journal of Drug Policy, Vol. 130

  2. Cocaine Effect Expectancies among Patients with Cocaine Use Disorder with and without Adult Attention Deficit Hyperactivity Disorder: Are There Any Relevant Differences?

    Journal of Psychoactive Drugs, Vol. 56, Núm. 1, pp. 76-87

  3. Distinct patterns of cell adhesion, migration, and morphology in olfactory neuroepithelium cells of bipolar disorder patients

    Molecular Medicine, Vol. 30, Núm. 1

  4. Influence of time to clozapine prescription on the clinical outcome

    Schizophrenia Research, Vol. 268, pp. 189-192

  5. Nerve Injury Triggers Time-dependent Activation of the Locus Coeruleus, Influencing Spontaneous Pain-like Behavior in Rats

    Anesthesiology, Vol. 141, Núm. 1, pp. 131-150

2023

  1. Multivariate Base Rates of Low Score on Neuropsychological Tests of Individuals with Coca Paste Use Disorder

    Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, Vol. 38, Núm. 5, pp. 793-802

  2. Shared decision making with schizophrenic patients: a randomized controlled clinical trial with booster sessions (DECIDE Study)

    Patient Education and Counseling, Vol. 110

2021

  1. Biomarkers of lithium response in neural progenitors of the olfactory neuroepithelium derived from patients with bipolar disorder

    34th European-College-of-Neuropsychopharmacology (ECNP) Congress on Early Career Scientists in Europe

  2. Factors associated with the use of mechanical restraint in a mental health hospitalization unit: 8-year retrospective analysis

    Journal of Psychiatric and Mental Health Nursing, Vol. 28, Núm. 6, pp. 1052-1064

  3. In-treatment changes in quality of life-related variables in therapeutic communities for cocaine abusers: Are these changes associated with clinical outcomes?

    International Journal of Environmental Research and Public Health, Vol. 18, Núm. 14

  4. Neuropsychological functioning of individuals with coca paste use disorder

    Addiction Research and Theory, Vol. 29, Núm. 4, pp. 298-305

  5. Satisfaction with antipsychotics as a medication: the role of therapeutic alliance and patient-perceived participation in decision making in patients with schizophrenia spectrum disorder

    International Journal of Psychiatry in Clinical Practice, Vol. 25, Núm. 3, pp. 268-276

  6. Trastorno por uso de cocaína y depresión: Cuando el diagnóstico clínico no es suficiente

    Adicciones: Revista de socidrogalcohol, Vol. 33, Núm. 3, pp. 193-200

  7. evidencias de validez y fiabilidad de la versión española de la "observable social cognition: A rating scale" (oscars) en pacientes con esquizofrenia

    Actas Espanolas de Psiquiatria, Vol. 49, Núm. 6, pp. 253-268

2020

  1. Internos en Centros Penitenciarios

    Manual de trastornos adictivos (J. Belarmino Bobes, M. Casas y M. Gutiérrez), pp. 315-322

  2. Predictive Outcome Validity of General Health Questionnaire (GHQ-28) in Substance Abuse Patients Treated in Therapeutic Communities

    Journal of Dual Diagnosis, Vol. 16, Núm. 2, pp. 218-227

  3. Towards a common metric for assessing heroin-dependent patient satisfaction with medications: Testing methadone and buprenorphine-naloxone

    Drug and Alcohol Dependence, Vol. 212

2019

  1. Monoaminergic system and depression

    Cell and Tissue Research, Vol. 377, Núm. 1, pp. 107-113

2018

  1. A cluster-analytic profiling of heroin-dependent patients based on level, clinical adequacy, and patient-desired adjustment of buprenorphine dosage during buprenorphine-naloxone maintenance treatment in sixteen Spanish centers

    Drug and Alcohol Dependence, Vol. 187, pp. 278-284